Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Freder1k-Study - Identification of Infants With Increased Type 1 Diabetes Risk for Enrollment Into Primary Prevention Trials

NCT03316261 is registered in ClinicalTrials.gov with Helmholtz Zentrum München as lead sponsor.

NCT NCT03316261
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03316261 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Freder1k-Study - Identification of Infants With Increased Type 1 Diabetes Risk for Enrollment Into Primary Prevention Trials
Lead sponsor
Helmholtz Zentrum München
Phase
Observational
Overall status
Recruiting
Start date
October 19, 2017
Completion date
August 31, 2027
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

identification of infants at risk for type 1 diabetes